J. Fallon et al., MPP(+) PRODUCES PROGRESSIVE NEURONAL DEGENERATION WHICH IS MEDIATED BY OXIDATIVE STRESS, Experimental neurology, 144(1), 1997, pp. 193-198
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, whi
ch produces Parkinsonism, is mediated by its metabolite 1-methyl-4-phe
nylpyridinium ion (MPP(+)). When injected into the striatum MPP(+) is
accumulated by dopaminergic nerve terminals and is then retrogradely t
ransported to the substantia nigra compacta. The mechanism by which it
mediates cell death involves both inhibition of complex I of the elec
tron transport chain and free radical generation. In the present exper
iments we found that administration of the free radical spin trap N-te
rt-butyl-alpha-(2-sulfophenyl) nitrone (S-PBN) significantly attenuate
d substantia nigra cell loss produced by MPP(+) administration into ra
t striatum. We also found that coadministration of coenzyme Q(10) with
nicotinamide, which attenuates energy depletion, significantly blocke
d MPP(+)-induced substantia nigra damage. Last, we found that a single
administration of MPP(+) into rat striatum can produce progressive ce
ll loss in the substantia nigra and that administration of S-PBN start
ing 7 days after administration of MPP(+) can block the ensuing neuron
al damage. These observations suggest that a one-time exposure to a ne
urotoxic agent may result in progressive neuronal degeneration mediate
d by oxidative stress. (C) 1997 Academic Press.